GLP-1 drugs don’t just lower blood sugar — they also make dangerous artery plaques more stable by reducing inflammation and strengthening the plaque’s outer shell, which helps prevent heart attacks...

GLP-1 drugs shrink a layer of fat that surrounds the heart — this fat is linked to heart disease, and shrinking it may help protect the heart from damage.

GLP-1 receptor agonists reduce cardiovascular event rates independently of LDL cholesterol modulation, primarily through weight loss and improved metabolic health.

GLP-1 drugs are changing the game for treating obesity because they help people lose more weight and improve heart and metabolic health better than older treatments.

If you're an overweight or obese adult without diabetes, taking GLP-1 drugs like Ozempic might lower your chances of having a heart attack by about 27% compared to taking a fake pill.

GLP-1 diabetes drugs help prevent heart attacks and strokes mainly by lowering blood sugar and helping people lose weight—not by lowering blood pressure or bad cholesterol.